All News & Stories

May 8, 2017

Graduate School Faculty Development and Research Symposium

Client Relationship Manager Kathy Carey will be representing Geneva at the upcoming Graduate School Faculty Development and Research Symposium (GSFDRS), “Rapidly Translating Evidence into Medical and Educational Readiness”, on 8-9 May. GSFDRS will be held at Joint Base San Antonio-Lackland Air Force Base in San Antonio, Texas. The purpose of the event is to foster

Read more
April 19, 2017

Naval Medical Center San Diego & Academic Research Competition

Clinical Trials Director Megan Wiese, Client Relationship Manager Kathy Carey, Grants & Contracts Manager Kasey Zink, Budget & Contract Manager Shawn Potts, and Site Manager Elissa Thomas will visit the Naval Medical Center San Diego (NMCSD) in San Diego, California. The team will meet with current and potential researchers and site employees whose studies include

Read more
March 27, 2017

Geneva Teams with Phelix Therapeutics and USAMRIID

Phelix Therapeutics is launching a collaboration with The Geneva Foundation and The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for continued research of a treatment for SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) via Phelix’s “novel viral fusion inhibitors for treating SARS/MERS coronaviruses”. SARS and MERS are coronaviruses

Read more
March 23, 2017

2017 Q1 Wave the Flag Recipient

Congratulations to Nicole Lackemer, Geneva’s 2017 1st Quarter Wave the Flag Recipient! Nicole Lackemeyer, a Research Scientist at U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), was nominated by Colonel Brian D. Moore. An excerpt from her nomination states: “Since 2013, Nicole has volunteered to be the suite supervisor for one of the three USAMRIID

Read more
March 7, 2017

San Antonio Ophthalmology Course

The 24th Annual San Antonio Ophthalmology Course (SAOC) will be held 7-11 March 2017. What began an intensive review for military ophthalmology residents based in San Antonio, the SAOC has grown to be an internationally recognized course with more than 250 civilian and military attendees annually. Formerly known as the Brooke Army Medical Center Ophthalmology Review Course, it

Read more
February 11, 2017

Study Update: Preventing Anti-Malaria Drug Resistance

Malaria is one of the most severe public health problems worldwide, with half the Earth’s population living in areas at risk of transmission. It is a leading cause of death and disease in many developing countries, where young children and pregnant women are the groups most affected. Malaria occurs mostly in poor, tropical, and subtropical

Read more
February 11, 2017

DNA Vaccine Delivery for Lassa Virus

Geneva researchers are collaborating with Inovio Pharmaceuticals to develop a way to improve DNA vaccine delivery for Lassa fever.   The Lassa virus causes a severe viral hemorrhagic fever that often presents itself alongside the Ebola virus. Those infected with Lassa virus experience respiratory distress, vomiting, facial swelling, chest pain, tremors, and brain inflammation. Lassa

Read more
January 31, 2017

2016 Q4 Wave the Flag Recipient

Congratulations to Seshamalini Srinivasan, Geneva’s 2016 4th quarter Wave the Flag Recipient! An excerpt from her nomination states: “Seshamalini – or ‘Sesh’ as we all call her – is a fabulous representative of our organization. Every day she embodies Geneva’s core values of Integrity, Quality, Innovation, Superior Customer Service, Teamwork, and Respect for All. She

Read more
January 30, 2017

University of Washington-Tacoma JBLM Leadership Luncheon

“Expertise can be taught, but character can’t necessarily be taught. Character is something that comes from within.” Wise words from Geneva’s Founder and Chief Strategy Officer, Jane Taylor, who joined a panel of Tacoma leaders on 30 January at the co-sponsored Leadership Luncheon, hosted by the University of Washington Tacoma (UW Tacoma) and Joint Base

Read more
January 11, 2017

Protection Against Hemorrhagic Fever with Renal Syndrome

Geneva researchers are working to develop a candidate combination DNA Vaccine for Hantavirus   Hantaviruses are part of the National Institute of Allergy and Infectious Diseases’ (NIAID) Category A priority pathogens list, identifying them as organisms/biological agents that pose the highest risk to national security and public health. These viruses are carried by persistently-infected rodents

Read more
1 2 12 13 14 15